Search Results

• • 29,378 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951)

  1

  Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951)

  Authors:Brigitte CM Haberkorn and Ferry ALM EskensFrom:Future Oncology (Vol. 9, Issue 1) Peer-Reviewed

  Jan. 20135,360 words Report 1500LAuthor(s): Brigitte CM Haberkorn [*] 2 , Ferry ALM Eskens 1 Keywords * angiogenesis; renal cell cancer; tivozanib; VEGFR tyrosine kinase inhibitor Angiogenesis is required for tumor growth and metastasis,...
• Select Gleevec for Pediatric ALL

  2

  Gleevec for Pediatric ALL

  From:MPR Hematology and Oncology Edition (Vol. 6, Issue 1)

  Spring 2013110 words Brief article 1270LGleevec (imatinib; Novartis) has been approved for use in combination with chemotherapy to treat children newly diagnosed with Philadelphia chromosome positive ([Ph.sub.+]) acute lymphoblastic leukemia (ALL). Imatinib...
• Select FDA approves two drugs for advanced melanoma

  3

  FDA approves two drugs for advanced melanoma

  Author:Elizabeth MechcatieFrom:Skin & Allergy News (Vol. 44, Issue 7)

  July 2013606 words Article 1560LTwo drugs that target mutations on the BRAF gene have been approved for treating metastatic or unresectable melanomas that express the mutations--along with a companion test to detect the mutations, the Food and Drug...
• Select Skin toxicity of targeted cancer agents: mechanisms and intervention

  4

  Skin toxicity of targeted cancer agents: mechanisms and intervention

  Authors:Viswanath Reddy Belum, Hiral Fontanilla Patel, Mario E Lacouture, and Ulrich RodeckFrom:Future Oncology (Vol. 9, Issue 8) Peer-Reviewed

  Aug. 20136,870 words Report 1520LAuthor(s): Viswanath Reddy Belum 1 , Hiral Fontanilla Patel 2 , Mario E Lacouture 1 , Ulrich Rodeck [*] 3 Keywords * BRAF; EGFR; immunomodulation; MEK; RAS/RAF/MEK/MAPK; skin toxicity; targeted agent...
• Select Smoking should stop when starting Sunitinib

  5

  Smoking should stop when starting Sunitinib

  From:Renal & Urology News (Vol. 13, Issue 1)

  Jan. 2014226 words Brief article 1590LPATIENTS STARTING sunitinib (Sutent) treatment for metastatic renal cell carcinoma (mRCC) should be advised to quit smoking, as active smoking appears to negatively affect progression-free and overall survival in such...
• Select Report of chronic myeloid leukemia from All India Institute of Medical Sciences, 1990-2010

  6

  Report of chronic myeloid leukemia from All India Institute of Medical Sciences, 1990-2010

  Authors:Pravas Mishra, Tulika Seth, Sudha Sazawal, Manoranjan Mahapatra, and Renu SaxenaFrom:Indian Journal of Medical and Paediatric Oncology (Vol. 34, Issue 3) Peer-Reviewed

  July-September 20132,592 words Report 1240LByline: Pravas. Mishra, Tulika. Seth, Sudha. Sazawal, Manoranjan. Mahapatra, Renu. Saxena All India Institute of Medical Sciences, New Delhi is an Apex Institute and caters to more than 1.5 million out-patients and...
• Select Optimizing quality control of docetaxel drug substance and its parenteral dosage forms

  7

  Optimizing quality control of docetaxel drug substance and its parenteral dosage forms

  Authors:M.S. Goizman, D.A. Arantseva, I.I. Demidova, M.B. Zagudailova, E.K. Kulaeva, M.G. Chernobrovkin, et al.From:Pharmaceutical Chemistry Journal (Vol. 47, Issue 9) Peer-Reviewed

  Dec. 20133,301 words Report 1310LAn HPLC method for quantitative determination of docetaxel and impurities in docetaxel drug substance and related dosage forms was developed for their quality control. Validation of the proposed method during the course...
• Select Anticancer potential of Conium maculatum extract against cancer cells in vitro: Drug-DNA interaction and its ability to induce apoptosis through ROS generation

  8

  Anticancer potential of Conium maculatum extract against cancer cells in vitro: Drug-DNA interaction and its ability to induce apoptosis through ROS generation

  Authors:Jesmin Mondal, Ashis Panigrahi, and Anisur Khuda-BukhshFrom:Pharmacognosy Magazine (Vol. 10, Issue 39) Peer-Reviewed

  Aug. 20145,220 words Report 1470LByline: Jesmin. Mondal, Ashis. Panigrahi, Anisur. Khuda-Bukhsh Objective: Conium maculatum extract is used as a traditional medicine for cervix carcinoma including homeopathy. However, no systematic work has so far...
• Select Pre-existing HTN benefits sunitinib recipients

  9

  Pre-existing HTN benefits sunitinib recipients

  From:Renal & Urology News (Vol. 13, Issue 7)

  July 2014166 words Brief article 1470LPRE-EXISTING hypertension (HTN) predicts improved overall and progression-free survival in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib, according to a French study presented at the...
• Select Anti-angiogenic therapies for advanced esophago-gastric cancer

  10

  Anti-angiogenic therapies for advanced esophago-gastric cancer

  Authors:Elisa Fontana, Francesco Sclafani, and David CunninghamFrom:Indian Journal of Medical and Paediatric Oncology (Vol. 35, Issue 4) Peer-Reviewed

  October-December 20146,650 words Report 2110LByline: Elisa. Fontana, Francesco. Sclafani, David. Cunningham Neo-vascularization is a vital process for tumor growth and development which involves the interaction between tumor cells and stromal endothelial cells...
• Select Reports on Apoptosis from Catholic University of Korea Provide New Insights (Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma)

  11

  Reports on Apoptosis from Catholic University of Korea Provide New Insights (Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma)

  From:Stem Cell Week

  Feb. 23, 2015417 words Article 1350LBy a News Reporter-Staff News Editor at Stem Cell Week -- A new study on Apoptosis is now available. According to news reporting originating in Seoul, South Korea, by NewsRx journalists, research stated, "Because the...
• Select Approval of cancer drugs often delayed

  12

  Approval of cancer drugs often delayed

  From:Benefits Canada (Vol. 38, Issue 8)

  Aug. 2014274 words Brief article 1610LCanada's organization In charge of reviewing cancer drugs often delays approvals while patients suffer and race against the clock, according to a recent study by the Fraser Institute. All new oncology drugs should...
• Select Findings from M. Emoto and Co-Authors Reveals New Information on Cancer Therapy (Azaspirene Analogs Inhibit the Growth of Human Uterine Carcinosarcoma In Vitro and In Vivo)

  13

  Findings from M. Emoto and Co-Authors Reveals New Information on Cancer Therapy (Azaspirene Analogs Inhibit the Growth of Human Uterine Carcinosarcoma In Vitro and In Vivo)

  From:Obesity, Fitness & Wellness Week

  June 20, 2015384 words Brief article, Repor... 1470L2015 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Oncology is the subject of a report. According to news originating from Fukuoka, Japan, by NewsRx...
• Select New Findings from Northwestern University in the Area of Hepatocellular Carcinoma Described (Systemic Therapy of Hepatocellular Carcinoma Current and Promising)

  14

  New Findings from Northwestern University in the Area of Hepatocellular Carcinoma Described (Systemic Therapy of Hepatocellular Carcinoma Current and Promising)

  From:Obesity, Fitness & Wellness Week

  June 20, 2015297 words Brief article, Repor... 1150L2015 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Digestive System Diseases and Conditions is the subject of a report. According to news reporting out of...
• Select Correction: Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin

  15

  Correction: Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin

  From:PLoS ONE (Vol. 9, Issue 9) Peer-Reviewed

  Sept. 30, 2014228 words Brief article, Corre... 640LAuthor(s): The PLOS ONE Staff Figure 2 was incorrectly published as a duplicate of Figure S2. Please see the correct Figure 2 here. Figure 2. Changes in cell interaction with fibronectin after inhibitor treatment....
• Select Researchers from University of Ioannina Report Recent Findings in Cancer Therapy (Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer)

  16

  Researchers from University of Ioannina Report Recent Findings in Cancer Therapy (Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer)

  From:Obesity, Fitness & Wellness Week

  Aug. 8, 2015402 words Article 1610L2015 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies have been published. According to news reporting originating from Ioannina,...
• Select Researchers at University of Copenhagen Release New Data on Labelled Compounds and Radiopharmaceuticals ([Cu-64]-labelled trastuzumab: optimisation of labelling by DOTA and NODAGA conjugation and initial evaluation in mice)

  17

  Researchers at University of Copenhagen Release New Data on Labelled Compounds and Radiopharmaceuticals ([Cu-64]-labelled trastuzumab: optimisation of labelling by DOTA and NODAGA conjugation and initial evaluation in mice)

  From:Obesity, Fitness & Wellness Week

  July 4, 2015397 words Article 1410L2015 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Drugs and Therapies have been presented. According to news reporting originating in Copenhagen,...
• Select Investigators at Ghent University Have Reported New Data on Hepatocellular Carcinoma (Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy)

  18

  Investigators at Ghent University Have Reported New Data on Hepatocellular Carcinoma (Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy)

  From:Obesity, Fitness & Wellness Week

  July 4, 2015487 words Report 1330L2015 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Digestive System Diseases and Conditions are discussed in a new report. According to news reporting...
• Select New Stem Cells Data Have Been Reported by Researchers at University of Dusseldorf (Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy)

  19

  New Stem Cells Data Have Been Reported by Researchers at University of Dusseldorf (Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy)

  From:Obesity, Fitness & Wellness Week

  July 25, 2015312 words Brief article 1610L2015 JUL 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Stem Cell Research have been presented. According to news reporting originating in Dusseldorf,...
• Select Findings in the Area of Cancer Therapies Reported from College of Pharmacy (Synthesis, anticancer and molecular docking studies of benzofuran derivatives)

  20

  Findings in the Area of Cancer Therapies Reported from College of Pharmacy (Synthesis, anticancer and molecular docking studies of benzofuran derivatives)

  From:Obesity, Fitness & Wellness Week

  Aug. 29, 2015272 words Brief article 1430L2015 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Drugs and Therapies. According to news reporting originating from Karnataka,...